HealthWarehouse.com, Inc. (HEWA)

HealthWarehouse.com, Inc. (HEWA) — VMCI valuation read

Headline read on HEWA: VMCI of 59/100 versus a Healthcare sector median of 50. The 9-point above-median position is what makes HealthWarehouse.com, Inc. a relative-value candidate in the mid-cap cohort, before any pillar-level review.

Form 4 filings on HEWA: zero in the trailing 30 days. The absence of insider transactions is itself a data point, just a low-information one. The thesis runs on financials and price action until that changes.

**Investor frame.** Three reads on HEWA: value (HEWA trades at 23.0x earnings, 28% above the Healthcare median of 18.0x), quality (ROIC of 19.0% sits 9.0pp above the Healthcare median (10.0%)), and risk (net debt to EBITDA of 2.0x is the rate-sensitivity line to watch). The value read also implies an EV/EBITDA gap of +4.0x against the Healthcare 12.0x baseline.

HEWA fell 1.4% over the trailing 7 days, with a +1.9% read on a 30-day basis.